ZA858169B - New adamantanamine derivatives,processes for their preparation and drugs in which they are present - Google Patents

New adamantanamine derivatives,processes for their preparation and drugs in which they are present

Info

Publication number
ZA858169B
ZA858169B ZA858169A ZA858169A ZA858169B ZA 858169 B ZA858169 B ZA 858169B ZA 858169 A ZA858169 A ZA 858169A ZA 858169 A ZA858169 A ZA 858169A ZA 858169 B ZA858169 B ZA 858169B
Authority
ZA
South Africa
Prior art keywords
derivatives
adamantanamine
new
present
drugs
Prior art date
Application number
ZA858169A
Other languages
English (en)
Inventor
Claude Laruelle
Marcel Lepant
Bernard Raynier
Original Assignee
Panmedica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panmedica Sa filed Critical Panmedica Sa
Publication of ZA858169B publication Critical patent/ZA858169B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
ZA858169A 1984-10-31 1985-10-24 New adamantanamine derivatives,processes for their preparation and drugs in which they are present ZA858169B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8416656A FR2572399B1 (fr) 1984-10-31 1984-10-31 Nouveaux derives de l'adamantanamine, leurs procedes de preparation et medicaments les contenant

Publications (1)

Publication Number Publication Date
ZA858169B true ZA858169B (en) 1986-06-25

Family

ID=9309181

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA858169A ZA858169B (en) 1984-10-31 1985-10-24 New adamantanamine derivatives,processes for their preparation and drugs in which they are present

Country Status (10)

Country Link
US (1) US4661512A (de)
EP (1) EP0187052B1 (de)
JP (1) JPS61109766A (de)
KR (1) KR920003837B1 (de)
AT (1) ATE49957T1 (de)
AU (1) AU583543B2 (de)
DE (1) DE3575715D1 (de)
ES (1) ES8702888A1 (de)
FR (1) FR2572399B1 (de)
ZA (1) ZA858169B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3609152A1 (de) * 1986-03-19 1987-09-24 Bayer Ag Verfahren zur herstellung des (-)-antipoden des (e)-1-cyclohexyl-4,4-dimethyl- 3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ens
FR2603888B1 (fr) * 1986-09-16 1990-12-21 Panmedica Sa Esters d'amino acides du trimethyl cyclohexanol, procede de preparation et utilisation comme medicaments
US5236946A (en) * 1986-09-16 1993-08-17 Panmedica S.A. Amino acid esters of cycloaliphatic alcohols and their use in treating lipemic disorders
DK0668290T3 (da) * 1990-02-28 1999-07-26 Teikoku Seiyaku Kk Fysiologisk aktiv substans, som er i stand til at gennemtrænge biomembranen
US5652335A (en) * 1990-02-28 1997-07-29 Teikoku Seiyaku Kabushiki Kaisha Physiologically active substance well capable of permeating biomembrane
AU6391594A (en) * 1994-02-01 1995-08-21 Board Of Regents Of The University Of Nebraska, The Polymeric adamantane analogues
US5880154A (en) * 1994-02-01 1999-03-09 The Board Of Regents Of The University Of Nebraska Polymeric adamantane analogues
JP2001518057A (ja) * 1995-07-07 2001-10-09 ダーハム ファーマシューティカルズ，エルエルシー 環状アミドおよびそれらの誘導体
DK0870757T3 (da) * 1997-04-10 2002-07-15 Pfizer Fluorsubstituerede adamantanderivater
CO5150173A1 (es) * 1998-12-10 2002-04-29 Novartis Ag Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
US6808716B2 (en) * 1999-01-08 2004-10-26 Ruey J. Yu N-acetylamino acids, related N-acetyl compounds and their topical use
US6159485A (en) 1999-01-08 2000-12-12 Yugenic Limited Partnership N-acetyl aldosamines, n-acetylamino acids and related n-acetyl compounds and their topical use
BR0311535A (pt) * 2002-06-03 2005-02-22 Novartis Ag Uso de cianopirrolidinas substituìdas e preparações de combinações contendo as mesmas para o tratamento da hiperlipidemia e doenças associadas
CA2565843A1 (en) * 2004-05-06 2005-11-17 Pfizer Inc. Novel compounds of proline and morpholine derivatives
JP2007102047A (ja) * 2005-10-07 2007-04-19 Dainippon Printing Co Ltd 商品管理用タグ

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3152180A (en) * 1960-08-25 1964-10-06 Studiengesellschaft Kohle Mbh Process for the production of nu-tert-alkyl amides and, if desired, nu-tert. alkyl amines
FR2622M (fr) * 1962-12-29 1964-06-29 Mundipharma Ag Nouveaux composés thérapeutiques.
US3345399A (en) * 1965-01-21 1967-10-03 Lilly Co Eli Carbamate esters of adamantane, mono-and di-methyladamantane and homoadamantane
US3374244A (en) * 1966-06-13 1968-03-19 Searle & Co N-(dialkylaminoalkyl)adamantanecarboxamides and related compounds
FR1575518A (de) * 1966-06-15 1969-07-25
US3682922A (en) * 1969-01-16 1972-08-08 Searle & Co N-acyl-n-{8 (n{40 ,n{40 -disubstituted amino)-alkyl{9 -1-adamantylmethylamines
BE754823A (fr) * 1969-08-13 1971-01-18 Merz & Co Derives de l'amonioadamantane et leur procede de preparation
JPS5581857A (en) * 1978-12-15 1980-06-20 Kyowa Hakko Kogyo Co Ltd Modifier of citrus fruit
US4273704A (en) * 1979-12-03 1981-06-16 G. D. Searle & Co. N-Adamantane-substituted tetrapeptide amides
US4296110A (en) * 1980-10-28 1981-10-20 E. I. Du Pont De Nemours And Company Antihypertensive I-substituted cyclic lactam-2-carboxylic acids
JPS5865269A (ja) * 1981-10-12 1983-04-18 Suntory Ltd ４置換（２ｓ，３ｓ，４ｓ）−２−カルボキシピロリジン−３−酢酸およびそのエステル
US4448972A (en) * 1982-02-22 1984-05-15 Smithkline Beckman Corporation Adamantyl containing intermediates
CS231221B1 (en) * 1982-06-29 1984-10-15 Martin Flegel L-alanyl-d-isoglutamine adamantylamide

Also Published As

Publication number Publication date
ES548357A0 (es) 1987-01-16
FR2572399A1 (fr) 1986-05-02
AU583543B2 (en) 1989-05-04
AU4884685A (en) 1986-05-08
DE3575715D1 (de) 1990-03-08
ATE49957T1 (de) 1990-02-15
KR860003219A (ko) 1986-05-21
FR2572399B1 (fr) 1987-01-16
EP0187052B1 (de) 1990-01-31
EP0187052A1 (de) 1986-07-09
JPS61109766A (ja) 1986-05-28
ES8702888A1 (es) 1987-01-16
KR920003837B1 (ko) 1992-05-15
US4661512A (en) 1987-04-28

Similar Documents

Publication Publication Date Title
ZA858169B (en) New adamantanamine derivatives,processes for their preparation and drugs in which they are present
IL75337A0 (en) Quinone derivative,process for the preparation thereof and pharmaceutical compositions containing the same
AU548974B2 (en) Oligoglucoside derivatives
ZA914133B (en) Preparation of substituted piperidines
NZ216048A (en) Quinolylglycinamide derivatives, and pharmaceutical compositions containing such
ES8606374A1 (es) Un procedimiento para preparar derivados de acido neuramini-co
ES8700655A1 (es) Un procedimiento para preparar derivados de pirrolidona
IL67835A0 (en) Imidazolidine derivatives,their preparation and pharmaceutical compositions containing them
EP0257572A3 (en) Thyronin derivatives
NZ279396A (en) Octahydro-6-hetring[2,1-a][2]benzazepine disulphide derivatives
EP0414020A3 (en) Process for the preparation of clausenamide and neoclausenamide and their derivatives
IE882897L (en) Azachromanes
GR1002174B (en) Novel 9a-hydroxy-3-ixi-4 24(25)-sigmastadien -26-dic acid derivatives and a process for preparing same
ES8401088A1 (es) Un procedimiento para la produccion de derivados de fosforamida.
ZA85275B (en) 3-alkoxy-2-(n-pyrrolidino)-n-pyridyl-n-furyl(or thienyl)methylpropylamines
ES8700245A1 (es) Procedimiento para la preparacion de derivados de 1,3,4-tia-diazol
EP0296979A3 (en) 1-benzoyl-2-oxo-5-alkoxy-pyrrolidine derivatives, their preparation, their use and preparations containing them
GB2175584A (en) Kojic acid derivatives and whitening cosmetics containing same
ES2049186A1 (es) Procedimiento para la preparacion de nuevos derivados de benzofuranil-imidazol.
ES2023760A6 (es) Procedimiento para la preparacion de derivados benzotiazinicos.
ES8504139A1 (es) Procedimiento para preparar derivados de bencimidazol.
ES8400412A1 (es) Procedimiento para la preparacion de nuevas sulfiminas.
IL71430A (en) 2-imino-n-phenylsulfonyl-imidazolidine derivatives,process for the manufacture thereof and pharmaceutical preparations containing such compounds